Vor Bio Says Experimental Drug Slowed Kidney Function Loss in Late-Stage Study

Vor Bio said its experimental kidney disease drug slowed the loss of kidney function and reduced the risk of disease progression in a late-stage study involving patients with IgA nephropathy.